Le Lézard
Classified in: Health
Subject: TDS

Applied BioMath, LLC Announces Presentation of Five Posters at the American Conference on Pharmacometrics (ACoP10)


CONCORD, Mass., Oct. 15, 2019 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, recently announced their participation in several conference sessions at ACoP10 occurring October 20-24, 2019 in Orlando, FL. They will also present the following posters at the conference.

(PRNewsfoto/Applied BioMath, LLC)

Monday, October 21st

Tuesday, October 22nd

Wednesday, October 23rd

"We are thrilled to present work that features collaborations with our scientific partners, including Biogen and Pfizer, and internal scientific projects," said John Burke, PhD, Co-founder, President and CEO, Applied BioMath. "These posters demonstrate the value of mechanistic and systems modeling and we are excited to share our science with the attendees at ACoP10."

For more information about Applied BioMath's presence at ACoP10, visit https://www.appliedbiomath.com/acop10.

About Applied BioMath
Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. Their Model-Aided Drug Invention (MADI) approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through clinical trials. The Applied BioMath team leverages their decades of expertise in biology, mathematical modeling and analysis, high-performance computing, and industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, patients, and the best path forward into and in the clinic. For more information about Applied BioMath and its services, visit www.appliedbiomath.com.

Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC.

Press contact:
Kristen Zannella
kristen.zannella@appliedbiomath.com

SOURCE Applied BioMath, LLC


These press releases may also interest you

at 13:42
Health Vector recently partnered with a major healthcare system to garner the power of AI to support medical documentation. The new product, Health Vector Clinical Transcriptions, demonstrates how instant transcription of medical encounters helps...

at 12:37
Essity's Half-year Report for 2020 will be published on Monday, July 13 at approximately 7:00 a.m. CET instead of Friday, July 17 as previously communicated. The reason for the earlier publishing date is the uncertainty entailed by the ongoing...

at 12:00
In lieu of an in-person update to the media, Dr. Howard Njoo, Canada's Deputy Chief Public Health Officer, issued the following statement on behalf of Dr. Theresa Tam, Canada's Chief Public Health Officer. "There have been 107,347 cases of COVID-19...

at 11:00
The latest data of the evolution of COVID-19 in Québec reveal 114 new cases over the past 24 hours, bringing the total number of people infected to 56,521. During the same period, 3 new deaths were recorded, to which are added 4 deaths that occurred...

at 08:35
Takeda Pharmaceutical Company Limited ("Takeda") (TSE: 4502/NYSE:TAK) today announced that 13 abstracts are being presented from the company's Hematology portfolio and pipeline at the International Society on Thrombosis and Haemostasis 2020 Virtual...

at 08:25
Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that following its application to The Stock Exchange of Hong Kong...



News published on 15 october 2019 at 15:24 and distributed by: